IL140581A0 - Bispiperidines as antithrombotic agents - Google Patents

Bispiperidines as antithrombotic agents

Info

Publication number
IL140581A0
IL140581A0 IL14058199A IL14058199A IL140581A0 IL 140581 A0 IL140581 A0 IL 140581A0 IL 14058199 A IL14058199 A IL 14058199A IL 14058199 A IL14058199 A IL 14058199A IL 140581 A0 IL140581 A0 IL 140581A0
Authority
IL
Israel
Prior art keywords
antithrombotic agents
bispiperidines
therepeutically
fibrinogen
iib
Prior art date
Application number
IL14058199A
Other languages
English (en)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of IL140581A0 publication Critical patent/IL140581A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14058199A 1998-07-17 1999-07-16 Bispiperidines as antithrombotic agents IL140581A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809166A FR2781223B1 (fr) 1998-07-17 1998-07-17 Bispiperidines et leurs applications therapeutiques
PCT/FR1999/001745 WO2000003986A1 (fr) 1998-07-17 1999-07-16 Bispiperidines comme agents antithrombotiques

Publications (1)

Publication Number Publication Date
IL140581A0 true IL140581A0 (en) 2002-02-10

Family

ID=9528732

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14058199A IL140581A0 (en) 1998-07-17 1999-07-16 Bispiperidines as antithrombotic agents
IL140581A IL140581A (en) 1998-07-17 2000-12-26 Bispiperidines, process for their preparation, pharmaceutical compositions containing them and their use in preparing antithrombotic medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140581A IL140581A (en) 1998-07-17 2000-12-26 Bispiperidines, process for their preparation, pharmaceutical compositions containing them and their use in preparing antithrombotic medicaments

Country Status (25)

Country Link
US (1) US6333338B1 (de)
EP (1) EP1098878B1 (de)
JP (1) JP2002520393A (de)
KR (1) KR100584032B1 (de)
CN (1) CN1286812C (de)
AT (1) ATE256661T1 (de)
AU (1) AU761655B2 (de)
BR (1) BR9912835A (de)
CA (1) CA2337776A1 (de)
DE (1) DE69913701T2 (de)
DK (1) DK1098878T3 (de)
EA (1) EA003674B1 (de)
ES (1) ES2212576T3 (de)
FR (1) FR2781223B1 (de)
HU (1) HUP0103623A3 (de)
IL (2) IL140581A0 (de)
NO (1) NO318963B1 (de)
NZ (1) NZ509170A (de)
PL (1) PL193804B1 (de)
PT (1) PT1098878E (de)
SK (1) SK152001A3 (de)
TR (1) TR200100159T2 (de)
UA (1) UA65631C2 (de)
WO (1) WO2000003986A1 (de)
ZA (1) ZA200100238B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047874A1 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
CA2529486A1 (en) * 2003-06-18 2004-12-23 Nst Neurosurvival Technologies Ltd. Method for selective targeting of apoptotic cells and small molecule ligands used thereof
AU2020300002A1 (en) 2019-07-01 2022-02-24 Tonix Pharma Limited Anti-CD154 antibodies and uses thereof
US20240059781A1 (en) 2021-01-06 2024-02-22 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.

Also Published As

Publication number Publication date
EP1098878A1 (de) 2001-05-16
EA200100150A1 (ru) 2001-08-27
DE69913701T2 (de) 2004-10-21
AU4629099A (en) 2000-02-07
IL140581A (en) 2006-12-31
DK1098878T3 (da) 2004-02-16
PL345418A1 (en) 2001-12-17
WO2000003986A1 (fr) 2000-01-27
BR9912835A (pt) 2001-10-09
CN1312799A (zh) 2001-09-12
NO20010252D0 (no) 2001-01-15
ES2212576T3 (es) 2004-07-16
TR200100159T2 (tr) 2001-06-21
HUP0103623A2 (hu) 2002-02-28
CA2337776A1 (en) 2000-01-27
EP1098878B1 (de) 2003-12-17
PT1098878E (pt) 2004-04-30
NO318963B1 (no) 2005-05-30
HUP0103623A3 (en) 2003-01-28
CN1286812C (zh) 2006-11-29
KR20010071925A (ko) 2001-07-31
DE69913701D1 (de) 2004-01-29
FR2781223A1 (fr) 2000-01-21
FR2781223B1 (fr) 2000-10-13
NO20010252L (no) 2001-03-19
US6333338B1 (en) 2001-12-25
SK152001A3 (en) 2001-11-06
EA003674B1 (ru) 2003-08-28
KR100584032B1 (ko) 2006-05-29
AU761655B2 (en) 2003-06-05
PL193804B1 (pl) 2007-03-30
ZA200100238B (en) 2001-11-21
UA65631C2 (en) 2004-04-15
JP2002520393A (ja) 2002-07-09
ATE256661T1 (de) 2004-01-15
NZ509170A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
GB9406857D0 (en) Improvements in or relating to organic compounds
NO933999L (no) Fibrinogenreseptorantagonister
ATE266399T1 (de) Neue substituierte triazolverbindungen
TR199701356A2 (xx) L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler.
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
ZA983055B (en) Fungicidal trifluorophenyl-triazolopyrimidines.
TR200000782T2 (tr) Resorsinol türevleri.
BG105028A (en) Bridged indenopyrrolocarbazoles
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
BG103096A (en) Thrombin inhibitors
EP1027056A4 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
IN2012DE00109A (de)
ZA943520B (en) N-alkylthio polyamine derivatives as radioprotective agents.
BG106019A (en) INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
MY133390A (en) Azabicyclic 5ht1 receptor ligands
PL345418A1 (en) Bispiperidines as antithrombotic agents
BG100248A (bg) Инхибитори на скваленсинтетаза
PT1282617E (pt) Derivados de hidantoína com afinidade para os receptores da somatostatina
ES8205126A1 (es) Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina.
AU1261395A (en) Antibodies which inhibit the binding of thrombin to platelets
EA199900959A1 (ru) Способы снижения содержания фибриногена
EP1205182A3 (de) Adenosine als Antithrombosemittel
BG102613A (en) New substituted imidazoles

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed